In Australia, women who claim to have been injured by the contraceptive drugs Yaz and Yasmin, both developed and manufactured by Bayer, are in the beginning stages of filing a…
The Yaz and Yasmin multidistrict litigation (MDL) convened for a status conference on September 4, 2013 in the U.S. District Court for the Southern District of Illinois. The court met…
A settlement agreement has been reached between Bayer and plaintiffs who filed a Yaz and Yasmin lawsuit specifically citing gallbladder complications. The settlement agreement between the plaintiffs and Bayer, the…
According to a Reuters report published on March 4, Bayer allocated $1.5 billion last year as a legal fund for Yaz and Yasmin lawsuits. In anticipation of future settlements of…
Carey Danis & Lowe Pradaxa lawyers are currently following the Pradaxa multi-district litigation (MDL) in Illinois. The Pradaxa MDL is In re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation MDL no….
In early November, the U.S. Food and Drug Administration (FDA) released a statement about its recent research into the incidence of excessive bleeding and Pradaxa use in patients with atrial…
Though the drug manufacturer denies Pradaxa as a defective drug, the surmounting Pradaxa bleeding deaths, injuries, and lawsuits prove otherwise. Pradaxa was introduced onto the U.S. drug market in October…
On December 19, the U.S. Food and Drug Administration (FDA) released a safety announcement regarding the anticoagulant medicine known as Pradaxa. Pradaxa, known generically as dabigatran etexilate mesylate, is manufactured…
The NuvaRing contraceptive device entered the market with insufficient safety information, as the product was never thoroughly studied, say plaintiffs who have filed NuvaRing lawsuits against the device’s manufacturer, Merck….
In a recent article on Yaz lawsuits from the Chicago Tribune, a former user of Yaz, 23 year old Maggie Yunker, described the injuries she incurred after a year of…